Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Cancer Letters
|
March 29, 2000
Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene
A Meye, P Würl, M Bache, et al.
The Journal of Pathology
|
May 16, 1998
No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas
A Meye, P Würl, R Hinze, et al.
International Journal of Oncology
|
June 16, 2001
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro
A Schindler, U Fiedler, A Meye, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 10, 2000
mdm2 mRNA level is a prognostic factor in soft tissue sarcoma
H Taubert, T Koehler, A Meye, et al.
International Journal of Oncology
|
July 17, 1998
Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcoma
A Meye, M Bache, R Hinze, et al.
Cancer Letters
|
May 24, 2000
Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease
H Schmidt, H Taubert, A Meye, et al.
Anticancer Research
|
September 2, 1999
G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines
M Bache, J Dunst, P Würl, et al.
Anticancer Research
|
August 6, 2000
A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data
P Würl, C Lautenschläger, A Meye, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
February 12, 1998
Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas
P Würl, A Meye, D Berger, et al.
Cancer
|
October 1, 1995
Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas
H Taubert, P Würl, A Meye, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Cancer Letters
|
March 29, 2000
Colony formation of soft tissue sarcoma cells is inhibited by lipid-mediated antisense oligodeoxynucleotides targeting the human mdm2 oncogene
A Meye, P Würl, M Bache, et al.
The Journal of Pathology
|
May 16, 1998
No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas
A Meye, P Würl, R Hinze, et al.
International Journal of Oncology
|
June 16, 2001
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro
A Schindler, U Fiedler, A Meye, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 10, 2000
mdm2 mRNA level is a prognostic factor in soft tissue sarcoma
H Taubert, T Koehler, A Meye, et al.
International Journal of Oncology
|
July 17, 1998
Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcoma
A Meye, M Bache, R Hinze, et al.
Cancer Letters
|
May 24, 2000
Gains in chromosomes 7, 8q, 15q and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease
H Schmidt, H Taubert, A Meye, et al.
Anticancer Research
|
September 2, 1999
G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines
M Bache, J Dunst, P Würl, et al.
Anticancer Research
|
August 6, 2000
A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data
P Würl, C Lautenschläger, A Meye, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
February 12, 1998
Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas
P Würl, A Meye, D Berger, et al.
Cancer
|
October 1, 1995
Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas
H Taubert, P Würl, A Meye, et al.
Page
of 5